Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma. The gene discussed is PDCD1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.